Hakon Blomstrand
Linkoeping, E, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
ASO Visual Abstract: Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer.
Journal: Annals of surgical oncology
Published: August 19, 2026
ASO Author Reflections: Understanding the Prognostic Role of Claudin 18.2 in Resected Pancreatic Cancer.
Journal: Annals of surgical oncology
Published: July 15, 2026
Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer.
Journal: Annals of surgical oncology
Published: March 03, 2026
Real-world evidence on second line chemotherapy in advanced biliary tract carcinoma refractory to gemcitabine and oxaliplatin (GemOx).
Journal: BMC cancer
Published: January 16, 2026
PCD-CT Versus EID-CT in Imaging of Pancreatic Ductal Adenocarcinoma: A Prospective Comparative Pilot Study.
Journal: Anticancer research
Published: February 08, 2025
Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine.
Journal: Oncology letters
Published: September 16, 2024
Impact of resection margins and para-aortic lymph node metastases on recurrence patterns and prognosis in resectable pancreatic cancer - a long-term population-based cohort study.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: March 10, 2023
Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer.
Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer.
Journal: World journal of clinical oncology
Published: February 28, 2021
Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer.
Journal: Frontiers in oncology
Published: February 16, 2020
Last Updated: 09/26/2026